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Abstract
Background: Human milk is an important source of bacteria for the developing infant and has been shown to
influence the bacterial composition of the neonate, which in turn can affect disease risk later in life. Very little is
known about what factors shape the human milk microbiome. The goal of the present study was to examine the
milk microbiota from a range of women who delivered vaginally or by caesarean (C) section, who gave birth to
males or females, at term or preterm.
Methods: Milk was collected from 39 Caucasian Canadian women, and microbial profiles were analyzed by 16S
ribosomal RNA (rRNA) sequencing using the Illumina platform.
Results: A diverse community of milk bacteria was found with the most dominant phyla being Proteobacteria and
Firmicutes and at the genus level, Staphylococcus, Pseudomonas, Streptococcus and Lactobacillus. Comparison of
bacterial profiles between preterm and term births, C section (elective and non-elective) and vaginal deliveries, and
male and female infants showed no statistically significant differences.
Conclusions: The study revealed the diverse bacterial types transferred to newborns. We postulate that there may
be a fail-safe mechanism whereby the mother is “ready” to pass along her bacterial imprint irrespective of when
and how the baby is born.
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Background
With the incidence of various non-infectious diseases on
the rise, there is much interest in the developmental ori-
gins of health and disease and the potential role of early
life feeding practices in modulating these outcomes.
Breast-fed infants have been shown to be better pro-
tected than formula-fed infants against necrotizing en-
terocolitis and diarrhoea, allergy and asthma,
inflammatory bowel disease, type 1 and type II diabetes,
obesity and cardiovascular disease [1, 2]. In addition to
immune protection and bioactive compounds being con-
veyed through maternal milk, a possible protective role
of bacteria has been suggested. Lower than average
levels of Bifidobacterium in human milk correlate with
low levels of Bifidobacterium in the neonatal gut [3],
allowing for higher than normal levels of Bacteroides to
be established [4]. These high levels of Bacteroides early
in life have been associated with an increased risk of
asthma and obesity later in life [5–7]. Indeed, efforts to
manipulate the microbiota of formula-fed infants
through probiotic supplementation have resulted in pro-
tection against some of the above diseases, comparable
to that observed for breast-fed infants [8–10].
Differences exist in bioactive components, macronutri-
ents, cytokines, enzymes, proteins and immunological
factors between preterm and term milk and milk from
mothers giving birth by vaginal and caesarean deliveries
[11–16]. As well, the energy content differs in milk de-
pending on gender of the newborn, with breast milk
from mothers who give birth to sons having more fat
content than that of daughters [17, 18].
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We hypothesized that physiological or hormonal trig-
gers that influence milk composition might also support
different bacterial genera. Thus, we studied human milk
samples from women giving birth at different stages of
gestation, by vaginal or caesarean delivery, and examined
whether gender of the newborn also affected the micro-
biota profiles.
Results
Characterization of the milk microbiota in 39 Canadian
women showed that despite diverse clinical parameters,
almost all had high abundances of Staphylococcus, En-
terobacteriaceae and Pseudomonas in their milk (Fig. 1)
(Additional file 1: Table S1). Overall, the top 6 most
abundant taxa represented in milk were Staphylococcus
(31 %), Enterobacteriaceae (10 %), Pseudomonas (17 %),
Streptococcus (5 %) and Lactobacillus (3 %) (Additional
file 2: Figure S1). Out of the 47 genera detected, half
(51 %) were present in all samples (Additional file 3:
Table S2). At the phylum level, Proteobacteria and Fir-
micutes made up the highest proportion of phyla in all
samples with Actinobacteria and Bacteroidetes also
present but at lower levels (Fig. 2).
No differences were detected in microbial profiles
based on gestation, mode of delivery or gender of the
child, using both weighted (Fig. 3a) and un-weighted
UniFrac distances (data not shown). The above two
matrices, however, assign a large emphasis on either rare
or highly abundant taxa, so compositional changes that
occur in moderately abundant lineages may be over-
looked [19]. For this reason, we also analyzed the data
using generalized UniFrac at an alpha of 0.5, which over-
comes this problem [19]. As with UniFrac, no differ-
ences were observed (Fig. 3b), but there was separation
of 13 samples, forming 2 distinct clusters, which could
not be explained by any of the other metadata that was
collected (Additional file 4: Figure S2) (Additional file 1:
Table S1). To further confirm the above results, we also
utilized the Bray-Curtis dissimilarity metric, which does
not take into account phylogenetic relatedness of the
biological community, as does UniFrac. As expected, no




































































































































Fig. 1 Breast milk microbiota in 39 Canadian women identified by 16S rRNA amplicon sequencing. The relative abundances of bacterial genera in
different human milk samples were visualized by bar plots. Each bar represents a subject and each coloured box a bacterial taxon. The height of a
coloured box represents the relative abundance of that organism within the sample. Taxa present in less than 2 % abundance in a given sample
are displayed in the “remaining fraction” at the top of the graph (grey boxes). As shown by the bar plots, a variety of bacteria were detected in
breast milk. The legend is read from bottom to top, with the bottom organism on the legend corresponding to the bottom coloured box on the
bar plot
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The dataset was also analyzed using ALDEx2 [41] to
examine whether specific taxa were differentially
expressed based on gestation, mode of delivery or
gender. Again, no differences were detected at the genus
(Additional file 6: Table S3), family, class or phyla levels
(data not shown).
Of interest, the abundance profiles clearly showed that
mothers are transmitting very different bacterial profiles
to newborns. For example, the milk of subject 40 con-
tained over 80 % abundance of staphylococci, whereas
that of subject 25 comprised mostly Gram-negative
organisms, especially Pseudomonas.
Discussion
This study revealed a range of bacterial genera in hu-
man milk, consistent with previous studies [20–22].
Interestingly, even when a baby was born extremely
prematurely (subject S24), the mother’s milk was
similar in composition to that of a woman giving
birth at full term (subject S30). It can be speculated
that this might be a fail-safe mechanism whereby the
mother is “ready” to pass along her bacterial imprint
irrespective of when the baby is born. If so, the
microbiota would appear to be recalcitrant to late
pregnancy hormonal and inflammatory changes,
which could indicate an evolutionary pressure protect-
ing this niche for the baby’s benefit. Further studies
on this concept are warranted, and cases where the
milk profiles are very different or the outcome for the
baby negative could be particularly insightful.
It was not surprising that milk from emergency caesar-
ean (C) section deliveries (i.e. non-elective) did not differ
from women who gave birth vaginally, as this decision is
made at the time of labour, when the hormones and tim-
ing for birth have been initiated. We also did not see dif-

























































































































Fig. 2 Percent abundances of bacterial phyla in breast milk identified by 16S rRNA sequencing. a The relative abundances of different phyla in
different breast milk samples were visualized by bar plots. b Box plots of the four phyla identified in breast milk. The box signifies the 75 % (upper)
and 25 % (lower) quartiles and thus shows where 50 % of the samples lie. The black line inside the box represents the median. The whiskers
represent the lowest datum still within 1.5 interquartile range (IQR) of the lower quartile and the highest datum still within 1.5 IQR of the upper
quartile. Outliers are shown with open circles. As shown, four phyla are represented in breast milk and present in all samples, with Proteobacteria
and Firmicutes being the most abundant
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Fig. 3 (See legend on next page.)
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vaginal births which is in contrast to a study published
by Cabrera-Rubio et al. in which they concluded that the
human milk microbiome is shaped by mode of delivery
[23]. However, we do not believe that the authors ad-
equately proved this claim. In their analysis, the milk
samples collected were from both obese and normal
weight women with no indication of the proportion in
each group. Since it was shown in that same paper that
body mass index influences the milk microbiota, the
subject’s weight could have been a confounding factor
responsible for the observed differences [23]. In addition,
the author’s claim that the milk microbiota is influenced
by mode of delivery was based solely on visual observa-
tions of bar plots (which were not very distinct between
the two groups), with no principal coordinate analysis
(PCoA) plots or statistical analyses to support this claim.
These conflicting results between our group and that of
Cabrera-Rubio highlight the need for future studies with
larger sample sizes and inclusion of women from various
demographics.
Because of the multivariate nature of the data, differ-
ences, if they are present, may have been masked by the
different variables confounding each other. Thus, a
larger sample size allowing for linear regression analysis
would strengthen our claims. However, there is the pos-
sibility that no matter the sample size, differences will
only be apparent when examined at the level of the indi-
vidual. Schwarzberg et al. [24] showed that treatment for
periodontitis had no effects on microbial profiles when
compared to controls. However, when pre- and post-
treatment effects for each individual were compared, sig-
nificant changes in bacterial composition were observed.
The authors thus emphasized the importance of com-
paring shifts from a personalized healthy state to a per-
sonalized disease state in order to truly understand
biological changes [24].
Proteobacteria and Firmicutes were the dominant
phyla, consistent with a previous high-throughput study
performed in Switzerland and analyzed with a different
sequencing platform (454 sequencing) [21].
The detection of Staphylococcus, as the most abun-
dant organism, is likewise consistent with other
studies [20–22]. Staphylococcus is more abundant in
the gut of breast-fed newborns compared to formula-
fed ones [25, 26], but their numbers start to decrease
after the first week of life when oxygen has been con-
sumed and an environment favourable for anaerobes
is created [4, 27]. Unlike Staphylococcus, which is
present in high abundance in at least the first week
of life, Proteobacteria are never found in high num-
bers in the faeces of newborns, infants or Western
adults [4, 28, 29]. Thus, an important question arises,
as to what the evolutionary significance is of having
such a diverse population of bacteria in milk, if only
a select few seem to colonize during the development
of the neonate. There are a few possibilities; firstly,
persistent colonization is not always needed for bene-
ficial effects, as transient exposure can be just as ef-
fective [30, 31]. Secondly, bacteria in milk may not
have to be passed on from the mother to the child to
exert their beneficial effects. Many of the protective
factors in milk such as antibodies, immune cells,
lactoferrin and beta defensins originate from the
mammary gland and not from the blood [32]. With
the ability of bacteria to regulate host gene expres-
sion, such as anti-microbials, and their ability to
stimulate the immune system, the plethora of bacteria
in breast milk could be inducing up-regulation of
these protective factors in the breast that then get
passed on in high concentrations to the neonate via
milk.
From another perspective, there is the possibility that
some of these milk microbes have either limited or no
effects on the offspring but are present for the benefit of
the mother, such as in the protection against mastitis.
Mastitis is a painful inflammatory condition of the breast
with the main causative agent being Staphylococcus
aureus, and it has been shown that some milk commen-
sals have the ability to prevent S .aureus growth and
infection [33]. The same is true for a skin derived strain
of Propionibacterium acnes, which prevents growth of S.
aureus via its by-products of glycerol fermentation [34].
With the high abundance of glycerol present in milk,
milk-derived strains of Propionibacterium may have
similar growth-inhibiting properties, which would
account for its presence in every milk sample collected.
Lactobacillus was present in high abundance in milk,
so for those women who deliver by C section and thus
(See figure on previous page.)
Fig. 3 Principal coordinate analysis (PCoA) plots comparing bacterial profiles based on gestation, mode of delivery and gender. PCoA plots based on
a weighted UniFrac distances or b generalized UniFrac distances at alpha 0.5. Each sample, represented by a coloured circle, is plotted on this two-
dimensional, two-axis plane with the first two components plotted. Samples (points) that cluster together are more similar in biota composition and
abundance. As shown by the plot, the lack of distinct clustering between groups, for gestation (1st row), mode of delivery (2nd row) and gender (3rd
row), indicate that no bacterial differences exist between preterm and term samples, caesarean and vaginal delivery samples, and male and female
samples. PERMANOVA (p < 0.5). P_ex = extremely premature (gestation <28 weeks); P_very = very premature (gestation 29–32 weeks); P_late = late
premature (gestation 33–36 weeks); T = term (gestation >37 weeks); “c_E” = elective caesarean delivery; “c_NE” = non-elective C section; “v” = vaginal
delivery; “m” =male child; “f” = female child; “m_tw” = twins both male; “f_tw” = twins both female; “Twin” =male and female twins
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do not transfer lactobacilli from the vagina to the infant,
the milk could provide a means for these beneficial or-
ganisms to reach the infant gut.
Conclusions
A diverse population of bacteria is present in breast milk
dominated by the phyla Proteobacteria and Firmicutes
and the taxa Staphylococcus, Pseudomonas, Enterobacte-
riaceae, Streptococcus and Lactobacillus. While no differ-
ences in microbial profiles were apparent based on
gestation, mode of delivery or gender, more studies are
still needed on what factors do influence bacterial com-
munities in milk and how these changes impact neonatal
and maternal health.
Methods
Milk collection and processing
A single milk sample (day 6 and onwards post-partum)
was collected from 39 Caucasian Canadian women re-
cruited from London, Ontario, and the surrounding area,
representing a homogenous community. Even though the
samples collected were from different days after birth,
with some considered “transitional” and others “mature,”
a Kendall’s tau correlation test showed no statistically sig-
nificant correlation between operational taxonomic unit
(OTU) relative abundances over time after a Benjamini-
Hochberg correction for multiple hypothesis tests. This
shows that it is acceptable to use all milk samples, regard-
less of when it was collected, in our analyses. Ethical
approval was obtained from Western Research Ethics
Board and Lawson Health Research Institute, London,
Ontario, Canada. Subjects provided written consent for
sample collection and subsequent analyses. Participants
were excluded if they were suffering from mastitis and
were/had been on antibiotics during lactation. Caesarean
deliveries were classified as either (i) “non-elective”, if
there were complications during labour, or (ii) “elective”, if
they were planned in advance or if the health of the foetus
and/or mother was at risk prior to labour.
Wearing sterile gloves, the women cleaned their nipple
and surrounding area with sterile saline swabs to reduce
the presence of skin bacteria. Milk was collected using a
sterile HygieniKit Milk Collection System (Ameda, Buffalo
Grove, IL, USA) attached to an electric breast pump.
Between 5 and 15 ml of milk was pumped into a sterile
tube and kept on ice until transfer to the laboratory, which
occurred within 1 h of collection. Samples were aliquoted
and stored at −20 °C until DNA extraction.
DNA isolation
After thawing on ice, 2 ml of milk were spun down at
20,000×g for 10 min and the supernatant was discarded.
The pellet was then homogenized in 1.4 ml of ASL buf-
fer (QIAamp® DNA Stool Kit, QIAGEN: Valencia, CA,
USA) and 400 mg of 0.1-mm diameter zirconium-glass
beads (BioSpec Products, Bartlesville, OK, USA). Mech-
anical and chemical lyses were performed by bead bead-
ing at 4800 rpm for 60 s, then 60 s on ice (repeated
twice) using a mini-beadbeater-1 (BioSpec Products) and
then incubated at 95 °C for 5 min. Subsequent proce-
dures were performed using the QIAGEN QIAamp®
DNA Stool Kit according to the manufacturer’s protocol,
with the exception of the last step in which the column
was eluted with 120 μl of elution buffer. DNA was
stored at −20 °C until further use.
A no template PCR control and a DNA extraction kit
reagent control were sequenced alongside the samples.
We observed that the taxon abundances in the controls
were uncorrelated with the abundances in the experi-
mental samples, and the distance between the controls
and samples was large. Thus, we conclude that the con-
trols had different profiles than that of the milk samples
(Additional file 7: Figure S4).
V6 16S rRNA gene sequencing
PCR amplification
The genomic DNA isolated from the clinical samples
was amplified using barcoded primers that amplify the
V6 hypervariable region of the 16S ribosomal RNA







nnnn indicates four randomly incorporated nucleotides
and “8” represents a specific sample barcode sequence.
The PCR was carried out in a 42 μl reaction containing
2 μl of DNA template (or nuclease-free water as a negative
control), 0.15 μg/μl bovine serum albumin, 20 μl of 2X
GoTaq hot start colourless master mix (Promega) and
10 μl of each primer (initial concentration 3.2 pmol/μl).
Thermal cycling was carried out in an Eppendorf Master-
cycler under the following conditions: initial denaturation
at 95 °C for 2 min followed by 25 cycles of 95 °C for
1 min, 55 °C for 1 min, and 72 °C for 1 min. After amplifi-
cation, the DNA concentration was measured with the
Qubit® 2.0 Fluorometer (Invitrogen) using the broad range
assay. Equimolar amounts of each PCR product were then
pooled together and purified using the QIAquick PCR
purification kit (QIAGEN). The pooled PCR purified sam-
ple was then paired end sequenced on the Illumina MiSeq
platform using a 150-cycle kit with a 2 × 80 run at the
London Regional Genomics Centre, London, ON, Canada,
following standard operating procedures.
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Sequence processing and taxonomic assignment
Custom Perl and Bash scripts were used to de-multiplex
the reads and assign barcoded reads to individual samples.
Multiple layers of filtering were employed: (i) Paired end
sequences were overlapped with Pandaseq, allowing zero
mismatch in the overlapped reads; (ii) Reads were kept if
the sequence included a perfect match to the V6 16S
rRNA gene primers; (iii) Barcodes were 8mers with an edit
distance of >4, and reads were kept if the sequence were a
perfect match to the barcode; (iv) Reads were clustered by
97 % identity into OTUs using the Uclust algorithm of
USEARCH v7 [35] which has a de novo chimera filter
built into it; and (v) All singleton OTUs were discarded,
and those that represented ≥1 % of the reads in at least
one sample were kept.
Taxonomic assignments for each OTU were made by
extracting the best hits from the SILVA database [36]
and then manually verified using the Ribosomal Data-
base Project (RDP) SeqMatch tool (rdp.cme.msu.edu)
and by BLAST against the Green genes database (green-
genes.lbl.gov). Taxonomy was assigned based on hits
with the highest percentage identities and coverage. If
multiple hits fulfilled this criterion, classification was re-
assigned to a higher common taxonomy. A summary of
each OTU classification and its sequence is shown in
Additional file 8: Table S4. The raw sequencing reads
generated in this study have been deposited to the NCBI
Short Read Archive (SRA) database accession # SRP
064311.
Data analysis
Weighted and un-weighted UniFrac distances [37] were
calculated in QIIME [38] by using a tree of OTU se-
quences built with FASTTREE [39] based on an OTU
sequence alignment made with MUSCLE [40]. The
QIIME pipeline was also used to generate PCoA plots to
visualize the Bray-Curtis dissimilarity. Changes in the
microbial community composition were also analyzed by
calculating the generalized UniFrac distance (alpha = 0.5,
rooted phylogenetic tree) using the GUniFrac package in
R, version 3.1.2 [19]. PERMANOVA was used to test for
statistical significance between the groups using 10,000
permutations (QIIME package). Bar plots, box plots,
stripcharts, PCoA plots and k means clustering analysis
were all generated in R (http://www.R-project.org/).
The ALDEx R package version 2 [41] was used to
compare genera, class, family and phyla between pre-
term and term milk; caesarean and vaginal deliveries,
and male and female children. Values reported in this
manuscript represent the expected values of 128 Dirich-
let Monte Carlo instances. A value of zero indicates that
organism abundance is equal to the geometric mean
abundance. Thus, organisms more abundant than the
mean will have positive values, and those less abundant
than the mean will have negative values. Base 2 was used
for the logarithm, so differences between values repre-
sent fold changes. Significance (p < 0.05) was based on
the Benjamini-Hochberg corrected p value of the
Welch’s t test and the Wilcoxon test.
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Additional file 2: Figure S1. Five most abundant genera in human
milk. Each point on the graph represents a subject, which indicates the
percent relative abundance of that genus within the sample. The line
represents the mean for all samples within the group. (PDF 25 kb)
Additional file 3: Table S2. Genera present in every milk sample.
(XLSX 57 kb)
Additional file 4: Figure S2. Principal coordinate analysis (PCoA) based
on generalized UniFrac distances. Each sample, represented by a
coloured circle, is plotted on this two-dimensional, two-axis plane with
the first two components plotted. Samples (points) that cluster together
are more similar in biota composition and abundance. GUniFrac, using an
alpha of 0.5 (which is more sensitive to changes in moderately abundant
taxa), was used to compare microbial profiles based on gestation, mode
of delivery and gender. While no differences were seen based on these
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Additional file 5: Figure S3. Bray-Curtis dissimilarity principal
coordinate (PCoA) plots comparing bacterial profiles based on gestation,
mode of delivery and gender. Each sample, represented by a coloured
circle, is plotted on this 3D, three-axis plane. Samples (points) that cluster
together are more similar in biota composition and abundance. As
shown by the plot, the lack of distinct clustering between groups, for
Gestation (1st row), mode of delivery (2nd row) and gender (3rd row),
indicate that no bacterial differences exist between preterm and term
samples, caesarean and vaginal delivery samples, and male and female
samples. P_ex = extremely premature (gestation <28 weeks); P_very = very
premature (gestation 29–32 weeks); P_late = late premature (gestation 33–
36 weeks); T = term (gestation >37 weeks); “c” = caesarean delivery; “v” =
vaginal delivery; “m” =male child; “f” = female child; “m_tw” = twins both
male; “f_tw” = twins both female; “Twin” =male and female twins.
(PDF 689 kb)
Additional file 6: Table S3. Comparison of relative abundances of
different genera detected in milk between preterm and term samples,
caesarean and vaginal deliveries, and male and female child. The values
reported for “rab.sample.” represents the base 2 logarithm of the relative
abundance of a specific genus within a sample. “rab.win..” represents the
base 2 logarithm of the median abundance of a specific genus in all
samples within a group (i.e. preterm samples or term samples) relative to
the geometric mean abundance, which has a value of 0. Thus, positive
values are higher than the geometric mean and are thus more abundant
than negative values, which are lower than the geometric mean.
Significance (p < 0.05) was based on the expected Benjamini-Hochberg
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corrected p value of the Welch’s t test (we.eBH) or the Wilcoxon test
(wi.eBH). we.ep and wi.ep represent the raw p value of the respective tests.
Out of the 47 genera identified, none were significantly different under any
condition. (XLSX 139 kb)
Additional file 7: Figure S4. Principal components analysis (PCA) biplot
comparing milk samples with controls. To verify that the microbiota
observed in our milk samples was not due to background contamination
from reagents in either the DNA extraction kit or from the PCR, a no
template PCR control (“NTC1”) and a tube of PBS that was extracted
alongside the milk samples (“reagent_control”) were sequenced. Data
presented in the biplot are from centred log ratio transformed values
[42]. As observed, the controls have a different microbial profile than the
milk samples. (PDF 24 kb)
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length V6 16S rRNA sequence of each operational taxonomic unit (OTU).
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